You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,815,835


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,815,835 protect, and when does it expire?

Patent 9,815,835 protects XOFLUZA and is included in two NDAs.

This patent has thirty-eight patent family members in seventeen countries.

Summary for Patent: 9,815,835
Title:Substituted polycyclic carbamolypyridone derivative
Abstract: This invention provides compounds having antiviral activities especially inhibiting activity for influenza virus, more preferably provides substituted 3-hydroxy-4-pyridone derivatives having cap-dependent endonuclease inhibitory activity.
Inventor(s): Akiyama; Toshiyuki (Osaka, JP), Takaya; Kenji (Osaka, JP), Kawai; Makoto (Osaka, JP), Taoda; Yoshiyuki (Osaka, JP), Mikamiyama; Minako (Osaka, JP), Morimoto; Kenji (Osaka, JP), Tomita; Kenji (Osaka, JP), Mikamiyama; Hidenori (Osaka, JP), Suzuki; Naoyuki (Osaka, JP)
Assignee: SHIONOGI & CO., LTD. (Osaka, JP)
Application Number:15/252,791
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,815,835

Introduction

United States Patent 9,815,835, titled "Substituted polycyclic carbamolypyridone derivative," is a patent that describes compounds with antiviral activities, particularly against the influenza virus. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

The patent, assigned the publication number US9815835B2, was granted to protect specific chemical compounds and their methods of use. Here is a brief overview:

  • Publication Number: US9815835B2
  • Authority: United States
  • Prior Art Keywords: Substituent group, optionally substituted, lower alkyl, etc.[4]

Scope of the Patent

The scope of the patent is defined by the claims, which outline the specific inventions and their applications that are protected.

Chemical Compounds

The patent describes a series of substituted polycyclic carbamolypyridone derivatives. These compounds are characterized by their chemical structure, which includes various substituent groups. The scope includes compounds with specific substituents such as lower alkyl groups, halogenated groups, and other functional groups that contribute to their antiviral properties[4].

Antiviral Activities

The primary focus of the patent is on the antiviral activities of these compounds, particularly their efficacy against the influenza virus. The scope extends to methods of using these compounds for treating or preventing influenza infections.

Claims Analysis

The claims section of the patent is crucial as it defines the legal boundaries of the invention.

Independent Claims

Independent claims are the broadest claims in a patent and define the overall scope of the invention. For US9815835B2, these claims typically include the general structure of the compounds and their use in treating viral infections.

Dependent Claims

Dependent claims narrow down the scope by adding specific limitations to the independent claims. These might include specific substituent groups, dosages, or methods of administration.

Claim Coverage and Scope Concepts

To understand the full coverage of the patent, it is helpful to use tools like a Claim Coverage Matrix and scope concepts.

  • Claim Coverage Matrix: This tool helps in identifying which patents and claims are actively protecting the intellectual property. It categorizes claims by their scope concepts, making it easier to filter and analyze large numbers of patent claims[3].
  • Scope Concepts: These are overarching categories that link claims on similar patents. For US9815835B2, scope concepts might include the type of substituent groups, the specific antiviral activities, and the methods of use.

Patent Landscape

Understanding the broader patent landscape is essential for assessing the value and potential of the patent.

Related Patents

The patent landscape includes other patents related to antiviral compounds, particularly those targeting the influenza virus. Tools like the Global Dossier and the Common Citation Document (CCD) can help in identifying related applications and prior art cited by various patent offices[1].

Competitors and Market

Analyzing the patent landscape also involves identifying competitors who may hold similar patents. This can be done through patent analytics services that track patents by claims and scope concepts, helping to identify gaps or opportunities in the market[3].

International Considerations

Since intellectual property protection is not limited to the United States, it is important to consider international patent filings and protections.

  • International Patent Offices: Databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) can be used to search for similar patents filed in other countries[1].

Practical Applications and Future Directions

The practical applications of the patent include the development of new antiviral drugs targeting the influenza virus. Future directions might involve further research into the efficacy and safety of these compounds, as well as exploring other potential uses.

Key Takeaways

  • Patent Scope: The patent protects specific chemical compounds and their use in treating viral infections.
  • Claims Analysis: Independent and dependent claims define the legal boundaries of the invention.
  • Patent Landscape: Understanding related patents and competitors is crucial for market positioning.
  • International Considerations: Global patent filings and protections must be considered.
  • Practical Applications: The patent has significant implications for the development of new antiviral drugs.

FAQs

Q: What is the primary focus of United States Patent 9,815,835? A: The primary focus is on the antiviral activities of substituted polycyclic carbamolypyridone derivatives, particularly against the influenza virus.

Q: How can one analyze the claims of a patent like US9815835B2? A: Using tools like a Claim Coverage Matrix and scope concepts can help in categorizing and analyzing the claims.

Q: What is the significance of the Global Dossier in patent searching? A: The Global Dossier provides access to the file histories of related applications from participating IP Offices, helping to identify prior art and related patents.

Q: How can one search for similar patents internationally? A: Databases from international patent offices such as the EPO, JPO, and WIPO can be used to search for similar patents filed in other countries.

Q: What are the potential future directions for the compounds described in US9815835B2? A: Future directions might include further research into efficacy and safety, as well as exploring other potential uses for these compounds.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office: https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. SLWIP - Patent Analytics: https://www.slwip.com/services/patent-analytics/
  4. Google Patents - US9815835B2: https://patents.google.com/patent/US9815835B2/en
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,815,835

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Genentech Inc XOFLUZA baloxavir marboxil FOR SUSPENSION;ORAL 214410-001 Nov 23, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Genentech Inc XOFLUZA baloxavir marboxil TABLET;ORAL 210854-001 Oct 24, 2018 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Genentech Inc XOFLUZA baloxavir marboxil TABLET;ORAL 210854-002 Oct 24, 2018 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Genentech Inc XOFLUZA baloxavir marboxil TABLET;ORAL 210854-003 Mar 18, 2021 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,815,835

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2009-142166Jun 15, 2009

International Family Members for US Patent 9,815,835

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 102482219 ⤷  Subscribe
China 102803260 ⤷  Subscribe
China 104151234 ⤷  Subscribe
China 104230795 ⤷  Subscribe
China 105037259 ⤷  Subscribe
Denmark 2444400 ⤷  Subscribe
European Patent Office 2412708 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.